Cannabis marketing study: do labels trick users into riskier choices?

NCT ID NCT07513337

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Johns Hopkins Bloomberg School of Public Health Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 21, 2026 · Updated 5 times

Summary

This study looks at how the labels and marketing claims on cannabis products affect what people think about the product's risks and effects. About 2,000 adults in states where recreational cannabis is legal will answer online survey questions after viewing a cannabis advertisement. The goal is to understand how marketing influences perceptions, expectancies, and willingness to use cannabis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help regulators understand how cannabis marketing affects user perceptions and intentions, potentially informing future labeling policies.
What could go wrong: This is an online survey study, not a clinical trial testing a treatment. Results are based on self-reported perceptions and may not reflect real-world behavior.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANNABIS USE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cannabis dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANNABIS USE

Contacts and locations

Locations

2213 McElderry St.

Baltimore, Maryland, 21205, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.